StatOrigin open statistical archive
Industries Indicators Regions Rankings Compare Sources

Long-term annual sales outlook

Projected long-term annual sales revenue target.

Unit billion GBP Industry Pharmaceuticals

Cite & reuse Get this data as JSON
Records
1
Regions
1
Period
2031
Sources
1
Verification 1 verified data points Updated 17 Sep 2026 Last verified 17 Sep 2026 Next update Sources typically refresh annually

The chart

The figure

One published observation so far. A chart follows as soon as a second period is published.

Long-term annual sales outlook

Global, 2031

1 observation
40 billion GBP Global · 2031 · GSK · full record
Source: GSK · CC BY 4.0 · statorigin.org

Every record

All records

1 record · 1 region · 2031

Download CSV JSON series
Long-term annual sales outlook: every record, grouped by region, newest first.
Period Value Source Type
Global 1 record
2031 40 billion GBP GSK · 31 Dec 2031 forecast

Primary documents

Sources

1 document. Each links to the publisher's own copy.

Document Publisher Published Data points
GSK delivers strong Q2 core results performance and continued momentum. Plans announced to accelerate R&D and late-stage pipeline portfolio. Expect 20+ phase III trial starts in 2026 GSK — 1

Cite & reuse

Cite this page

Data on this page is published under CC BY 4.0. You may reuse it, including commercially, provided you attribute it. To cite one figure, open its record: each carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.

StatOrigin. (2026). Long-term annual sales outlook. Retrieved from https://statorigin.org/indicators/long-term-annual-sales-outlook

Download CSV Get this data as JSON Compare with… API docs